NCT06285851View on ClinicalTrials.gov

A Novel Iron Supplement for Athletes: Phase I

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

December 12, 2023

Study Completion Date

December 12, 2023

Conditions
ConstipationDiarrheaCramp, AbdominalBleeding Gastric
Interventions
DIETARY_SUPPLEMENT

FeSC

Supplement

Trial Locations (1)

Unknown

University of Calgary, Calgary

All Listed Sponsors
collaborator

Lallemand Bio-Ingredients

OTHER

lead

University of Calgary

OTHER

NCT06285851 - A Novel Iron Supplement for Athletes: Phase I | Biotech Hunter | Biotech Hunter